AVAX AVXT Stock
AVAX Price Chart
AVAX AVXT Financial and Trading Overview
AVAX stock price | 0.0000 USD |
Previous Close | 1.0E-6 USD |
Open | 1.0E-6 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 1.0E-6 - 1.0E-6 USD |
52 Week Range | 1.0E-6 - 0.0001 USD |
Volume | 2K USD |
Avg. Volume | 10.5K USD |
Market Cap | 64.17K USD |
Beta (5Y Monthly) | -39.013733 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (2.16%) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AVXT Valuation Measures
Enterprise Value | 3.1M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.4503298 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 21.767 |
Enterprise Value/EBITDA | -0.528 |
Trading Information
AVAX Stock Price History
Beta (5Y Monthly) | -39.013733 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0001 USD |
52 Week Low | 1.0E-6 USD |
50-Day Moving Average | 0.0001 USD |
200-Day Moving Average | 0.0001 USD |
AVXT Share Statistics
Avg. Volume (3 month) | 10.5K USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 0 |
Float | N/A |
Short Ratio | 0 |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | 0 |
Short % of Float | N/A |
Short % of Shares Outstanding | 0% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2010 |
Most Recent Quarter (mrq) | December 31, 2010 |
Next Fiscal Year End | December 31, 2011 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -4151.67% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -457.31% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 142.5K USD |
Revenue Per Share (ttm) | 0.001 USD |
Quarterly Revenue Growth (yoy) | 374.90% |
Gross Profit (ttm) | 142.5K USD |
EBITDA | -5873681 USD |
Net Income Avi to Common (ttm) | -11993094 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 86.4K USD |
Total Cash Per Share (mrq) | 0 USD |
Total Debt (mrq) | 3.19M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.019 |
Book Value Per Share (mrq) | -0.038 |
Cash Flow Statement
Operating Cash Flow (ttm) | -3439805 USD |
Levered Free Cash Flow (ttm) | -2413159 USD |
Profile of AVAX
Country | United States |
State | PA |
City | Philadelphia |
Address | 2000 Hamilton Street |
ZIP | 19130 |
Phone | 215-241-9760 |
Website | https://www.avax-tech.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 9 |
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.
Q&A For AVAX Stock
What is a current AVXT stock price?
AVAX AVXT stock price today per share is 0.0000 USD.
How to purchase AVAX stock?
You can buy AVXT shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AVAX?
The stock symbol or ticker of AVAX is AVXT.
Which industry does the AVAX company belong to?
The AVAX industry is Biotechnology.
How many shares does AVAX have in circulation?
The max supply of AVAX shares is 0.
What is AVAX Price to Earnings Ratio (PE Ratio)?
AVAX PE Ratio is now.
What was AVAX earnings per share over the trailing 12 months (TTM)?
AVAX EPS is 0 USD over the trailing 12 months.
Which sector does the AVAX company belong to?
The AVAX sector is Healthcare.